Findings

What do systematic reviews say?

2,922 questions · 3,118 findings · 513 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 574 · 18.4%GRADE not reported 372 · 11.9%Very low 723 · 23.2%Low 854 · 27.4%Moderate 489 · 15.7%High 106 · 3.4%

Intervention not reported

Medium‐ versus low‐dose · children (from 1 to 18 years of age) with hypertension from primary or secondary causes

1 finding from 1 review

Pharmacological interventions for hypertension in children 2014 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 139 participants
Very low

Intervention not reported

High vs low dose Systolic blood pressure · children (from 1 to 18 years of age) with hypertension from primary or secondary causes

1 finding from 1 review

Pharmacological interventions for hypertension in children 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 141 participants
Very low

Intervention not reported

High vs low dose Diastolic blood pressure · children (from 1 to 18 years of age) with hypertension from primary or secondary causes

1 finding from 1 review

Pharmacological interventions for hypertension in children 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 141 participants
Very low

First‐line chemotherapy vs BSC

Overall survival · patients with extensive SCLC without previous treatment

1 finding from 1 review

Chemotherapy versus best supportive care for extensive small cell lung cancer 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 65 participants
Very low

First‐line chemotherapy vs BSC

Adverse effects · patients with extensive SCLC without previous treatment

1 finding from 1 review

Chemotherapy versus best supportive care for extensive small cell lung cancer 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 65 participants
Very low

Intervention not reported

Overall survival · patients with extensive SCLC who relapsed or progressed after first‐line chemotherapy

The intervention may leads to lower overall survival (low certainty).

1 finding from 1 review

Chemotherapy versus best supportive care for extensive small cell lung cancer 2013 · Cochrane Headline outcomes only
HR 0.73 [0.55, 0.96]
2 studies · 542 participants
Low

Intervention not reported

Toxic death · patients with extensive SCLC who relapsed or progressed after first‐line chemotherapy

1 finding from 1 review

Chemotherapy versus best supportive care for extensive small cell lung cancer 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 542 participants
Moderate

Intervention not reported

Adverse effects · patients with extensive SCLC who relapsed or progressed after first‐line chemotherapy

1 finding from 1 review

Chemotherapy versus best supportive care for extensive small cell lung cancer 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 542 participants
Moderate

Intervention not reported

Quality of life · patients with extensive SCLC who relapsed or progressed after first‐line chemotherapy

The intervention may leads to higher quality of life (low certainty).

1 finding from 1 review

Chemotherapy versus best supportive care for extensive small cell lung cancer 2013 · Cochrane Headline outcomes only
RR 2.18 [0.05, 0.25]
1 study · 141 participants
Low

Intervention not reported

Hospital length of stay (high‐risk surgical patients) · Adult patients in intensive care

1 finding from 1 review

Pulmonary artery catheters for adult patients in intensive care 2013 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 503 participants
High

Intervention not reported

Cost of care (hospital charges, 1000s of US dollars) · Adult patients in intensive care

1 finding from 1 review

Pulmonary artery catheters for adult patients in intensive care 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 191 participants
Low

Intervention not reported

Combined mortality of all studies · Adult patients in intensive care

The intervention leads to higher combined mortality of all studies (high certainty).

1 finding from 1 review

Pulmonary artery catheters for adult patients in intensive care 2013 · Cochrane Headline outcomes only
RR 1.01
13 studies · 5686 participants
High

Intervention not reported

Adherence · people with glaucoma or ocular hypertension

1 finding from 1 review

Interventions for improving adherence to ocular hypotensive therapy 2013 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 902 participants
Low

Intervention not reported

Intraocular pressure · people with glaucoma or ocular hypertension

1 finding from 1 review

Interventions for improving adherence to ocular hypotensive therapy 2013 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 503 participants
Very low

Intervention not reported

Visual field defects · people with glaucoma or ocular hypertension

1 finding from 1 review

Interventions for improving adherence to ocular hypotensive therapy 2013 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 301 participants
Very low

Intervention not reported

Quality of life · people with glaucoma or ocular hypertension

1 finding from 1 review

Interventions for improving adherence to ocular hypotensive therapy 2013 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 265 participants
Very low

Intervention not reported

Adverse effects · people with glaucoma or ocular hypertension

1 finding from 1 review

Interventions for improving adherence to ocular hypotensive therapy 2013 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 650 participants
Very low

Intervention not reported

Persistence · people with glaucoma or ocular hypertension

1 finding from 1 review

Interventions for improving adherence to ocular hypotensive therapy 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 127 participants
Low

Intervention not reported

Intraocular pressure · people with glaucoma or ocular hypertension

1 finding from 1 review

Interventions for improving adherence to ocular hypotensive therapy 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 193 participants
Low

Intervention not reported

Visual field defects · people with glaucoma or ocular hypertension

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for improving adherence to ocular hypotensive therapy 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found